Sign In
Buy SGPYY
$42.52
+0.0600 (+0.141%)
At Close: Jun 23, 2026
Why Is Depression-Focused Sage Therapeutics Stock Surging Higher On Monday?
09:38am, Monday, 13'th Jan 2025
On Friday, Sage Therapeutics Inc. SAGE confirmed that Biogen Inc. BIIB submitted an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics not already owned
Sage Therapeutics Stock Rockets 35% Higher After Takeover Bid From Biogen
07:24am, Monday, 13'th Jan 2025
The biopharmaceutical company says its board of directors will now review and evaluate the offer from Biogen.
Sage Therapeutics to Present 2025 Strategic Focus at 43rd Annual J.P. Morgan Healthcare Conference
06:00pm, Sunday, 12'th Jan 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that Chief Executive Officer Barry Greene will discuss the Company's strategic focus areas for 2025 at the 43r
Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen
06:49pm, Friday, 10'th Jan 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) (“The Company”), today confirmed that Biogen Inc. (Nasdaq: BIIB) (“Biogen”) has submitted to the Company an unsolicite
Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
06:30am, Wednesday, 08'th Jan 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2
Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
07:00am, Tuesday, 26'th Nov 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), today announced that the Company will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference o
The Sage Group plc (SGGEF) Q4 2024 Earnings Call Transcript
07:54pm, Friday, 22'nd Nov 2024
The Sage Group plc (OTCPK:SGGEF) Q4 2024 Earnings Conference Call November 20, 2024 3:30 AM ET Company Participants Steve Hare - Chief executive officer Jonathan Howell - Chief Financial Officer Confe
AssetMark Adds TIFIN AI Capabilities to Enhance and Scale its Industry-Leading Wealth Management Platform
08:30am, Thursday, 21'st Nov 2024
TIFIN Sage's AI-driven Technology Empowers AssetMark to Deliver Highly Personalized Solutions for Financial Advisors TIFIN Sage's AI-driven Technology Empowers AssetMark to Deliver Highly Personalized
After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
10:36am, Wednesday, 20'th Nov 2024
On Wednesday, Sage Therapeutics Inc SAGE revealed topline results from the Phase 2 DIMENSION Study of dalzanemdor (SAGE-718) in participants with cognitive impairment (CI) associated with Huntington'
Sage Therapeutics to end Huntington's disease trial after key therapy fails again
07:34am, Wednesday, 20'th Nov 2024
It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as a treatment for mild cognitive impairment and mild dementia in Alzheimer's
Sage Therapeutics scraps development of rare disease drug after it fails mid-stage study
06:58am, Wednesday, 20'th Nov 2024
Sage Therapeutics will stop development of its experimental drug to treat cognitive impairment in patients with Huntington's disease after it failed a mid-stage study, the drug developer said on Wedne
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced topline results from the Phase 2 DIMENSION Study of dalzanemdor (SAGE-718) in participants with cognitive impa
Sage Group surges as annual profit margins expand on cloud software sales
03:39am, Wednesday, 20'th Nov 2024
Sage Group PLC (LSE:SGE) shares surged 17% to 1,275p after the accounting software group reported improving profit margins and announced a £400 million. share buyback In the year to 30 September, re
UK software firm Sage Group reports 21% rise in profit
02:14am, Wednesday, 20'th Nov 2024
Britain's Sage Group reported a better-than-expected 21% rise in full-year operating profit to 529 million pounds ($672 million) driven by a 220 basis points margin increase, and said it expected cont
Baker Manufacturing Expands its Water Systems Division Through the Acquisition of the Pump Division of A.Y. McDonald
11:00am, Monday, 04'th Nov 2024
AUSTIN, Texas--(BUSINESS WIRE)--Baker Manufacturing Company, LLC (“Baker”), an Evansville, WI-based portfolio company of Blue Sage Capital (“Blue Sage”), is pleased to announce its acquisition
